Meeting
2013 ASCO Annual Meeting
Gene expression profiling (GEP) to predict the primary site of metastatic neuroendocrine tumors (NETs) presenting with an unknown primary.
Authors
Eugene Woltering
Louisiana State University Health Sciences Center, Kenner, LA
Eugene Woltering , Lowell Brian Anthony , Anne E. Diebold , J Philip Boudreaux , Yi-Zarn Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Neuroendocrine/Carcinoid
Citation
J Clin Oncol 31, 2013 (suppl; abstr 4141)
DOI
10.1200/jco.2013.31.15_suppl.4141
Abstract #
4141
Poster Bd #
31C
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for novel therapeutic targets.
First Author: Cecilia Grace Ethun
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comprehensive genomic profiling of squamous cell carcinoma of unknown primary presenting with liver metastases.
First Author: Hannah Ruth Robinson
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Phase 2 study of nab-sirolimus in patients with well-differentiated and advanced/metastatic neuroendocrine tumors of the gastrointestinal tract, lung, or pancreas.
First Author: Michael J. Demeure
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical and radiological response to locoregional and systemic treatments in well-differentiated gastroenteropancreatic neuroendocrine tumors with liver metastases treated at a reference center in Mexico.
First Author: Cesar Arce Sandoval